Overview

Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients

Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
0
Participant gender:
Female
Summary
compare the effectiveness of different doses of dexamethasone used for postoperative nausea and vomiting prophylaxis in obese patients and in normal weight patients.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Diskapi Yildirim Beyazit Education and Research Hospital
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate
Criteria
Inclusion Criteria:

High risk patients for postoperative nausea and vomiting:

- Female

- No smoking

- BMI =18.5-24.9 for control group

- BMI >30 for other groups

- undergo laparoscopic cholecystectomy

Exclusion Criteria:

- Diabetes mellitus